G-207

N/A

Report date: 2023/03/22 20:00:51

Base Information

Drug NameG-207
Drug Alias Nameoncolytic herpes simplex virusHSV mutantsG-207 virus constructG-207
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionRibonucleotide reductase inhibitors
TargetsRibonucleotide reductase
Therapy Area/IndicationsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases +[22] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedigene Ag
China Registration ClassN/A

Develop Information

Active CompaniesMatica Biotechnology IncTreovir IncThe University Of Texas MD Anderson Cancer Center +[4] 
Inactive CompaniesMedigene Inc
Active IndicationsBrain DiseasesCentral Nervous System DiseasesNeoplasm Metastasis +[20] 
Inactive IndicationsNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia